Efficacy of Prednisolone Versus Cerebrolysin in the Treatment of Bell's Palsy
Recruiting now · Phase 1/Phase 2
Conditions studied: Bell Palsy
In brief
Bell's palsy, a peripheral facial nerve paresis, is the most common disorder of the facial nerve and one of the most common mononeuropathies. Many patients with Bell's palsy will develop some complications such as synkinesis, crocodile tears and 'sweating' of the ear while eating Commonly used medications to treat Bell's palsy is Corticosteroids Cerebrolysin stimulates the regeneration of the nervous tissue with protective action we aim to study the efficacy of cerebrolycin in Bell's palsy
Key facts
- Study ID
- NCT05821075
- Run by
- October 6 University
- People needed
- 90
- Starts
- 2023-08-24
- Expected to finish
- 2026-02-01
- Last updated by the study team
- 2025-07-31
Who can join
Age: 18 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- unilateral acute facial palsy of no identifiable cause
You may not qualify if…
- Recurrent facial Bell's palsy
- Pregnancy
- Diabetes
- Epilepsy
- Severe hypertension,
- Renal or hepatic disease,
- Gastric or duodenal ulcer
- presence of acute otitis media or ipsilateral chronic otitis
- Recent head injury,
- psychiatric disease
- If there is any contraindications for corticosteroids
Where it is running
- October 6 university hospital — Giza, Egypt (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.